2018
Impact of Health Insurance Status on Prostate Cancer Treatment Modality Selection in the United States
Bledsoe T, Park H, Rutter C, Aneja S, Nguyen PL, Yu J. Impact of Health Insurance Status on Prostate Cancer Treatment Modality Selection in the United States. American Journal Of Clinical Oncology 2018, 41: 1062-1068. PMID: 29521648, DOI: 10.1097/coc.0000000000000423.Peer-Reviewed Original ResearchTreatment modality selectionInsurance statusTreatment modalitiesProstate cancerPrivate insuranceProstate cancer treatment modalitiesMultivariable logistic regression analysisInvasive surgeryModality selectionCancer-directed treatmentD'Amico risk classificationTreatment modality choiceNational Cancer DatabaseLocalized prostate cancerPatient insurance statusExternal beam radiotherapyLogistic regression analysisHealth insurance statusStrongest predictorMen ages 18Cancer treatment modalitiesClinical factorsMultivariable analysisActive surveillanceCancer Database
2017
Is Active Surveillance the Preferred Management for Men with Early-Stage Prostate Cancer? A Decision Analysis Using the Protect Trial
Bledsoe T, Stahl J, Johnson S, Nath S, Yu J, Lester-Coll N. Is Active Surveillance the Preferred Management for Men with Early-Stage Prostate Cancer? A Decision Analysis Using the Protect Trial. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: s206-s207. DOI: 10.1016/j.ijrobp.2017.06.512.Peer-Reviewed Original Research
2015
Evaluation at Academic Centers Increases the Likelihood of Active Surveillance in Low-Risk Prostate Cancer
Lester-Coll N, Park H, Rutter C, Corso C, Mancini B, Yeboa D, Kim S, Gross C, Yu J. Evaluation at Academic Centers Increases the Likelihood of Active Surveillance in Low-Risk Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s118. DOI: 10.1016/j.ijrobp.2015.07.281.Peer-Reviewed Original Research